Corporate Shareholder Information

Stock Transfer Agent and Registrar

The principal market for our Common Stock is the New York Stock Exchange. Our stock is also traded on various U.S. regional stock exchanges.

Stock Transfer Agent and Registrar
Computershare Investor Services

P.O. Box 43006
Providence, RI 02940-3006
Telephone: (800) 733-9393
Outside the U.S., Canada and Puerto Rico:
(781) 575-4591
Internet: is external)

Shareholder Services and Programs

Please contact our Stock Transfer Agent and Registrar, Computershare, with inquiries concerning shareholder accounts of record and stock transfer matters, and for information:

  • Computershare Investment Program
  • Direct purchase of Pfizer stock
  • Dividend reinvestment
  • Automatic monthly or bi-monthly investments
  • Book-entry share ownership
  • Direct deposit of dividends

Pfizer Public Policy Engagement for Global Public Health

Learn more about public policy at Pfizer:

We may use our website as a means of disclosing material information and for complying with our disclosure obligations under Regulation Fair Disclosure promulgated by the SEC. These disclosures are included on our website in the “About-Investors” or “News” sections. Accordingly, investors should monitor these portions of our website, in addition to following Pfizer’s press releases, SEC filings, public conference calls and webcasts, as well as Pfizer’s social media channels (Pfizer’s Facebook, Instagram, YouTube and LinkedIn pages and Twitter accounts (@Pfizer, @PfizerInc and @Pfizer_News)).

The information contained on our website, our Facebook, YouTube and LinkedIn pages or our Twitter accounts is not incorporated by reference into this 2022 Annual Review.

The 2022 Annual Review may contain references or links to other websites maintained by third parties over whom Pfizer has no control. Such links are provided merely as a convenience. Pfizer makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such third-party websites, and a link to this 2022 Annual Review from another website does not imply a relationship between Pfizer and any third party. Your use of any such third-party site or platform is at your own risk and will be governed by such third party’s terms and policies (including its privacy policy).